Premium
Age‐related differences in susceptibility to toxic effects of valproic acid in rats
Author(s) -
Espandiari Parvaneh,
Zhang Jun,
Schnackenberg Laura K.,
Miller Terry J.,
Knapton Alan,
Herman Eugene H.,
Beger Richard D.,
Hanig Joseph P.
Publication year - 2008
Publication title -
journal of applied toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.784
H-Index - 87
eISSN - 1099-1263
pISSN - 0260-437X
DOI - 10.1002/jat.1314
Subject(s) - valproic acid , toxicity , pharmacology , medicine , chemistry , toxicology , epilepsy , biology , psychiatry
Abstract A multi‐age rat model was evaluated as a means to identify a potential age‐related difference in liver injury following exposure to valproic acid (VPA), a known pediatric hepatotoxic agent. Different age groups of Sprague‐Dawley (SD) rats (10‐, 25‐, 40‐, 80‐day‐old) were administered VPA at doses of 160, 320, 500 or 650 mg kg −1 (i.p.) for 4 days. Animals from all age groups developed toxicity after treatment with VPA; however, the patterns of toxicity were dissimilar within each age group. The high dose of VPA caused significant lethality in 10‐ and 25‐day‐old rats. All doses of VPA caused decrease in the platelet counts (10‐, 25‐day‐old rats) and the rate of growth (40‐day‐old rats) and increases in the urine creatine concentration (high dose, 80‐day‐old rats). VPA induced hepatic and splenic alterations in all age groups. The most severe lesions were found mostly in 10‐ and 80‐day‐old rats. Significant changes in blood urea nitrogen, alanine aminotransferase and alkaline phosphatase were observed in 10‐day‐old pups after treatment with low doses of VPA. The highest VPA dose caused significant decreases in the levels of serum total protein (40‐ and 80‐day‐old rats). Principal component analysis of spectra derived from terminal urine samples of all age groups showed that each age group clusters separately. In conclusion, this study showed that the vulnerability profile of each age group was different indicating that a multi‐age pediatric animal model is appropriate to assess more completely age‐dependent changes in drug toxicity. Published in 2007 by John Wiley & Sons, Ltd.